Literature DB >> 15100274

The magnitude of TCR engagement is a critical predictor of T cell anergy or activation.

Saied Mirshahidi1, Laura C Korb Ferris, Scheherazade Sadegh-Nasseri.   

Abstract

Fast dissociation rate of peptide-MHC complexes from TCR has commonly been accepted to cause T cell anergy. In this study, we present evidence that peptides that form transient complexes with HLA-DR1 induce anergy in T cell clones in vitro and specific memory T cells in vivo. We demonstrate that similar to the low densities of long-lived agonist peptide-MHC, short-lived peptide-MHC ligands induce anergy by engagement of approximately 1000 TCR and activation of a similar pattern of intracellular signaling events. These data strongly suggest that short-lived peptides induce anergy by presentation of low densities of peptide-MHC complexes. Moreover, they suggest that the traditional antagonist peptides might also trigger anergy by a similar molecular mechanism. The use of short-lived peptides to induce T cells anergy is a potential strategy for the prevention or treatment of autoimmune diseases.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15100274     DOI: 10.4049/jimmunol.172.9.5346

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  15 in total

1.  Increased T-cell reactivity and elevated levels of CD8+ memory T-cells in Alzheimer's disease-patients and T-cell hyporeactivity in an Alzheimer's disease-mouse model: implications for immunotherapy.

Authors:  Katharina Schindowski; Anne Eckert; Jürgen Peters; Corinna Gorriz; Uta Schramm; Thomas Weinandi; Konrad Maurer; Lutz Frölich; Walter E Müller
Journal:  Neuromolecular Med       Date:  2007-10-26       Impact factor: 3.843

2.  The SCHOOL of nature: I. Transmembrane signaling.

Authors:  Alexander B Sigalov
Journal:  Self Nonself       Date:  2010-01

3.  Superantigen-induced CD4 memory T cell anergy. I. Staphylococcal enterotoxin B induces Fyn-mediated negative signaling.

Authors:  Andrew R O Watson; David K Janik; William T Lee
Journal:  Cell Immunol       Date:  2012-02-17       Impact factor: 4.868

4.  Suboptimal stimulation by weak agonist epitope variants does not drive dysfunction of HIV-1-specific cytotoxic T lymphocyte clones.

Authors:  Mark A Grossman; Christian Hofmann; Hwee L Ng; Otto O Yang
Journal:  AIDS       Date:  2019-08-01       Impact factor: 4.177

Review 5.  Suboptimal engagement of the T-cell receptor by a variety of peptide-MHC ligands triggers T-cell anergy.

Authors:  Scheherazade Sadegh-Nasseri; Sarat K Dalai; Laura C Korb Ferris; Saied Mirshahidi
Journal:  Immunology       Date:  2009-12-02       Impact factor: 7.397

6.  Peptide-MHC class II complex stability governs CD4 T cell clonal selection.

Authors:  Christina K Baumgartner; Andrea Ferrante; Mika Nagaoka; Jack Gorski; Laurent P Malherbe
Journal:  J Immunol       Date:  2009-12-09       Impact factor: 5.422

7.  Multiple genetic programs contribute to CD4 T cell memory differentiation and longevity by maintaining T cell quiescence.

Authors:  Nianbin Song; Srona Sengupta; Stanislav Khoruzhenko; Robin A Welsh; AeRyon Kim; Mithra R Kumar; Søren Ulrik Sønder; John-William Sidhom; Hao Zhang; Chunfa Jie; Robert F Siliciano; Scheherazade Sadegh-Nasseri
Journal:  Cell Immunol       Date:  2020-09-05       Impact factor: 4.868

8.  Subtle changes in TCRα CDR1 profoundly increase the sensitivity of CD4 T cells.

Authors:  Jennifer N Lynch; David L Donermeyer; K Scott Weber; David M Kranz; Paul M Allen
Journal:  Mol Immunol       Date:  2012-09-14       Impact factor: 4.407

9.  Anergy in memory CD4+ T cells is induced by B cells.

Authors:  Sarat K Dalai; Saied Mirshahidi; Alexandre Morrot; Fidel Zavala; Scheherazade Sadegh-Nasseri
Journal:  J Immunol       Date:  2008-09-01       Impact factor: 5.422

10.  Conservation and diversity of influenza A H1N1 HLA-restricted T cell epitope candidates for epitope-based vaccines.

Authors:  Paul Thiamjoo Tan; A T Heiny; Olivo Miotto; Jerome Salmon; Ernesto T A Marques; Francois Lemonnier; J Thomas August
Journal:  PLoS One       Date:  2010-01-18       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.